Panupong Hansrivijit | Health Professions | Best Researcher Award

Posted on by Book of Award

Dr. Panupong Hansrivijit | Health Professions | Best Researcher Award

Brigham and Women's Hospital | United States

Author Profile

Scopus

Orcid

Google Scholar

🌟 Early Academic Pursuits

Dr. Panupong Hansrivijit embarked on his medical journey at Chulalongkorn University, where he graduated with first-class honors in medicine. His passion for internal medicine and nephrology led him to pursue an internship at Thammasat University Hospital, where he gained extensive clinical experience in patient care and medical procedures. This strong academic foundation set the stage for his future endeavors in nephrology research and clinical excellence.

🏥 Professional Endeavors

Dr. Hansrivijit’s medical career took him to the United States, where he completed his Internal Medicine Residency at UPMC Harrisburg. This period was crucial in shaping his skills in patient diagnosis, management, and research methodologies. Currently, he is a Nephrology Fellow at Brigham and Women’s Hospital/Massachusetts General Hospital, specializing in managing complex kidney disorders, dialysis, and transplantation. Simultaneously, he is advancing his expertise in public health through a Master of Public Health (MPH) at Harvard T.H. Chan School of Public Health.

🔬 Contributions and Research Focus

Dr. Hansrivijit has made significant contributions to the field of nephrology, particularly in chronic kidney disease, dialysis, kidney transplantation, and pharmaco-epidemiology. His research spans multiple areas, including machine learning applications in kidney disease prediction, outcomes of kidney transplant recipients, and the impact of metabolic disorders on renal health. His extensive list of publications reflects his dedication to evidence-based medicine and improving patient outcomes.

🏆 Accolades and Recognition

Dr. Hansrivijit's groundbreaking work has earned him multiple prestigious awards, including the Best Researcher Award (2025) from both the International Environmental Awards and the International Invention Awards. His achievements also include multiple Kidney STARS Program Awards from the American Society of Nephrology, a Travel Grant Award from the International Society of Nephrology, and recognition for his contributions to global nephrology research.

🌍 Impact and Influence

Beyond his clinical and research work, Dr. Hansrivijit is an active member of the nephrology community, holding memberships in renowned organizations such as the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN). His contributions in meta-analyses, systematic reviews, and nephrology-based epidemiological research have influenced treatment strategies and policy discussions on kidney disease management worldwide.

🚀 Legacy and Future Contributions

With a growing portfolio of influential research and clinical expertise, Dr. Hansrivijit is set to become a leader in nephrology innovation. His future contributions will likely focus on improving dialysis techniques, optimizing transplant outcomes, and utilizing data-driven methodologies to enhance patient care. His dedication to advancing kidney health and public health policies ensures that his impact will be felt for generations to come.

Publications

  • 📄 Utilization Trends of Glucose-Lowering Medications Among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States
    Author(s): Panupong Hansrivijit, Helen Tesfaye, Deborah J. Wexler, Elisabetta Patorno, Julie M. Paik
    Journal: Journal of Clinical Medicine
    Year: 2025

  • 📄 A Hospice Transitions Program for Patients in the Emergency Department
    Author(s): Christopher William A. Baugh, Kei Ouchi, Jason K. Bowman, Elizabeth M. Rickerson, Mallika Lakshmi Mendu
    Journal: JAMA Network Open
    Year: 2024

  • 📄 Unpacking Contributors to CKD Incidence and Progression: Time to Move Beyond Traditional Risk Factors
    Author(s): Panupong Hansrivijit, Lipika Samal, Mallika Lakshmi Mendu
    Journal: American Journal of Kidney Diseases
    Year: 2023

  • 📄 Hepatitis E Virus Infection in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis
    Author(s): Angkawipa Trongtorsak, Natapat Chaisidhivej, Kritika Yadav, Wisit Cheungpasitporn, Panupong Hansrivijit
    Journal: Journal of Investigative Medicine
    Year: 2022

  • 📄 Renal Manifestations of Hepatitis E Among Immunocompetent and Solid Organ Transplant Recipients
    Author(s): Karthik Reddy Kovvuru, Nicholas Carbajal, Abhinandan Reddy Pakanati, Wisit Cheungpasitporn, Swetha Rani Kanduri
    Journal: World Journal of Hepatology
    Year: 2022

 

Pawan Gupta | Health Professions | Best Researcher Award

Posted on by Book of Award

Dr. Pawan Gupta | Health Professions | Best Researcher Award

Innovative Cancer Care and Rehabilitation Pvt. Ltd | India

Author Profile

Scopus

Orcid

🌟 Early Academic Pursuits

Dr. Pawan Gupta’s academic journey reflects his passion for excellence in oncology and surgical practice. He graduated with an MBBS degree in 1991 from SCB Medical College, Cuttack, followed by an MS in General Surgery in 1996. In 2001, he completed his M.Ch. in Onco-Surgery at Gujarat University, further enhancing his skills with training at the Tata Memorial Hospital in Mumbai. His international exposure includes earning the FRCS I from the Royal College of Surgeons, Glasgow, and advanced training in voice rehabilitation and photodynamic therapy. These formative years laid the foundation for his groundbreaking career in cancer care.

🏥 Professional Endeavors

As the Senior Director of Head and Neck Cancer Surgery at MAX Institute of Cancer Care, Dr. Gupta has made significant strides in oncology. He is the visionary founder of ICanCaRe, a pioneering platform dedicated to cancer care and tobacco deaddiction. Through innovative tools like the ICanCaRe App, Virtual Clinics, and the National Quitline, his work has revolutionized patient rehabilitation. Additionally, his leadership roles include serving as National President and Senior Vice Chairman of the I CAN WIN Foundation, where he champions cancer prevention and treatment initiatives.

📚 Contributions and Research Focus

Dr. Gupta’s research and contributions are pivotal in advancing cancer care. With over 30 publications in esteemed journals and authorship of six influential books, he has enriched both the academic and practical fields of oncology. His patented instrument, TrisCaRe, demonstrates his commitment to innovation, addressing specific challenges in oral cancer treatment. As a master trainer for tobacco cessation under Gujarat University, Dr. Gupta has trained more than 1,000 specialists, cementing his role in global health initiatives.

🏅 Accolades and Recognition

Dr. Gupta’s impactful work has earned him numerous prestigious awards, including the ICD International Award (2007), the Vivekananda Sister Margarette Award (2017), and the Inspiring Oncologist 2024 Award by Times Network. These accolades honor his relentless dedication to cancer care, tobacco cessation, and public health advocacy.

🌍 Impact and Influence

Dr. Gupta’s influence extends far beyond clinical practice. His motivational talk, "Making of Cancer Winners," delivered at the Livestrong Global Summit in Dublin, inspired a global audience. His campaigns, such as "Win Over Cancer" and "Save the Youth – Win Over Tobacco," have garnered widespread recognition, transforming public attitudes toward cancer prevention and tobacco deaddiction.

🌱 Legacy and Future Contributions

Dr. Gupta’s holistic approach to oncology and his visionary projects, such as ICanCaRe, ensure his lasting legacy in the fight against cancer. As he continues to innovate and inspire, his work paves the way for a healthier, cancer-free future. His dedication to research, public education, and compassionate care underscores a career marked by transformative achievements and unwavering commitment to humanity.

 

Publications

📝 Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs
Authors: Kannan, S., Gokul Krishna, S., Gupta, P.K., Kolkundkar, U.K.
Journal: Scientific Reports
Year: 2024

📝 Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease
Authors: Gupta, P.K., Shivashankar, P., Rajkumar, M., Manjuprasad, M.S., Udaykumar, K.
Journal: Stem Cell Research and Therapy
Year: 2023

📝 Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
Authors: Gupta, P.K., Maheshwari, S., Cherian, J.J., Verma, N.N., Kumar, U.
Journal: American Journal of Sports Medicine
Year: 2023

📝 Comparison of guidelines for biological ancillary materials used for the manufacture of gene and cellular therapy products in Asia
Authors: Tanaka, T., Yoshimura, K., Chang, R., Zhao, X., Takakura, K.
Journal: Cytotherapy
Year: 2023

 

Sejal Parekh | Health Professions | Best Researcher Award

Posted on by Book of Award

Ms. Sejal Parekh | Health Professions | Best Researcher Award

NHS England | United Kingdom

Author Profile

Orcid

Early Academic Pursuits 📚

Sejal Parekh embarked on her academic journey with a Master of Pharmacy (MPharm) from University College London, where she honed her expertise in pharmaceutical sciences. In 2017, she furthered her education with a Master’s in Clinical Research (MRes), funded by the NIHR. This strong academic foundation in pharmacy and clinical research equipped her with a comprehensive understanding of quantitative and qualitative research methodologies.

Professional Endeavors 💼

Sejal’s career spans diverse roles within both hospital and community pharmacy settings. She has been instrumental in leading national quality improvement initiatives, particularly as a Senior Project/Policy Manager at NHS England. Her role involved developing criteria for the Pharmacy Quality Scheme (PQS) and liaising with stakeholders like NHS Digital, Public Health England, and the Pharmaceutical Services Negotiating Committee (PSNC). Her work, particularly during the pandemic, led to the implementation of infection control measures, influencing community pharmacy operations across the country.

Contributions and Research Focus 🔬

Sejal's contributions are deeply rooted in antimicrobial stewardship, service delivery, and policy writing. A notable project was her leadership in the NSAID safety audit within community pharmacies, where she identified a significant gap in gastroprotection for patients on NSAIDs. Her findings prompted recommendations that improved patient safety in primary care, aligning with the WHO Global Patient Safety Challenge. Sejal has co-authored several reports and articles that are widely recognized within the medical community.

Accolades and Recognition 🏆

Throughout her career, Sejal has received several awards, including:

  • HSJ Winner: Patient Safety Team of 2023 for her work on the Pharmacy Quality Scheme.
  • She was also the Pre-registration Trainee Pharmacist of the Year for London (2003) and a GlaxoSmithKline Prize recipient for her work on smoking cessation.

Her accolades underscore her dedication to patient safety and innovative pharmaceutical care.

Impact and Influence 🌍

Sejal's work has had a profound impact on community pharmacy in the UK. Her development of safer prescribing initiatives and infection control protocols, especially during the COVID-19 pandemic, has contributed to national improvements in healthcare delivery. Her ability to collaborate across teams and organizations has resulted in smoother policy implementations and improved patient outcomes.

Legacy and Future Contributions 🌟

As a thought leader in pharmacy, Sejal Parekh’s legacy is built upon her pioneering work in antimicrobial stewardship and patient safety. Her ongoing contributions to the Pharmacy Quality Scheme and national healthcare initiatives demonstrate her commitment to improving service quality. With her recent role as a Programme Manager for NHS England, Sejal is poised to continue making impactful changes in the healthcare landscape. Her future endeavors will likely include further innovations in pharmacy services, ensuring continued excellence in patient care.

 

Publications

  • 📚 "An Evaluation of Oral Anticoagulant Safety Indicators by England’s Community Pharmacies"
    Journal: Pharmacy, Year: 2024
    Authors: Sejal Parekh, Lingqian Xu, Carina Livingstone
  • 📚 "Responding to Urinary Tract Infection Symptoms in England’s Community Pharmacies"
    Journal: Antibiotics, Year: 2023
    Authors: Sejal Parekh, Kieran S Hand, Lingqian Xu, Victoria Roberts, Fionna Pursey, Diane Ashiru-Oredope, Donna Lecky
  • 📚 "The National Implementation of a Community Pharmacy Antimicrobial Stewardship Intervention (PAMSI) through the English Pharmacy Quality Scheme 2020 to 2022"
    Journal: Antibiotics, Year: 2023
    Authors: Catherine Hayes, Sejal Parekh, Donna Lecky, Jill Loader, Carry Triggs-Hodge, Diane Ashiru-Oredope
  • 📚 "ESPAUR Report 2021 to 2022 Chapter 5: NHS England Improvement and Assurance Schemes"
    Journal: Medical Sciences Forum, Year: 2023
    Authors: Kieran S Hand, Diane Ashiru-Oredope, Elizabeth Beech, Sabine Bou-Antoun, Gillian Damant, Naomi Fleming, Catherine Hayes, Philip Howard, Conor Jamieson, Monsey McLeod et al.
  • 📚 "National Antimicrobial Stewardship Activities in Primary and Secondary Care in England 2021–22 (ESPAUR Report)"
    Journal: Medical Sciences Forum, Year: 2023
    Authors: Ella Casale, Catherine Hayes, Donna Lecky, Luke O’Neil, Eirwen Sides, Emily Cooper, Fionna Pursey, Sejal Parekh, Eleanor J. Harvey, Diane Ashiru-Oredope